glp 1 acne A meta-analysis of the incidence of vulgaris in patients treated with GLP-1 agonists Ozempic Face: The Effects of

The insight most users miss: IGF-1 LR3's extended half-life (2030 hours vs 10 minutes for endogenous IGF-1) means systemic circulation, not localized muscle activation

doi: 10.1111/j.0022-202X.2004.22404.x

Type 2 diabetes | Treatment summaries | BNF NICE

As T2D is often associated with having a high body mass index, one would be forgiven for assuming that the needs of people who use GLP-1s for weight loss and those using it to treat diabetes would be very similar, but recent market research suggests a number of significant differences:5 The majority of people using GLP-1s for weight loss are in their 30s to 50s (often as part of a wider strategy to be proactive about their health), whereas those using GLP-1s for diabetes control are more likely to be over 60